Formulated initially to mimic GLP-1 , a hormone that helps regulate blood sugar levels, semaglutide interacts with receptors in the body to promote insulin secretion, which is especially beneficial for individuals with type 2 diabetes
Step 5: Follow-Up and Maintenance Monthly follow-up visits track weight changes, review any side effects, and adjust the dose as needed
The affected genes cluster in several functional categories directly relevant to skin biology
On November 6th, the Trump administration reached an agreement with Novo Nordisk and Eli Lilly to substantially lower the cost of key GLP-1 medications, such as Wegovy and Zepbound, for millions, including Medicare recipients
Here is how the leading options stack up: | Feature | Semaglutide | Tirzepatide | Retatrutide | Liraglutide | |---------|-------------|-------------|-------------|-------------| | **Mechanism** | GLP-1 | GLP-1 + GIP | GLP-1 + GIP + Glucagon | GLP-1 | | **Dosing** | Weekly | Weekly | Weekly | Daily | | **Max Dose** | 2.4mg | 15mg (FDA) | 12mg (trial) | 3mg | | **Avg Weight Loss** | 15-17% | 20-22% | 22-24% | 8-10% | | **FDA Approved** | Yes | Yes | Phase 3 | Yes | | **Oral Option** | Yes (Rybelsus) | No | No | No | ## Semaglutide (Ozempic / Wegovy): The Proven Standard Semaglutide was the medication that transformed obesity treatment from a niche specialty into mainstream medicine
These products are generally sold online in lyophilized (freeze-dried) powder form and positioned for research use